Centre Oscar Lambret

Lille

OncologyPhase II

What changed

Phase II trial registered: Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall

3w agoTrial registeredJun 22, 2026Source filing (opens the source filing in a new tab)

Momentum

79no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Trial
PHASE2 registered
Jun 1, 2026
Soft Tissue Sarcoma Adult, Soft Tissue Sarcoma (Excluding GIST), Soft Tissue Sarcoma of the Trunk and Extremities, Soft Tissue Sarcoma of the Limb · RECRUITING · sponsor: Centre Oscar Lambret · Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall
ClinicalTrials.gov · NCT07507773 (opens the source filing in a new tab)
Trial
NA registered
Nov 3, 2017
Cervical Cancer · COMPLETED · sponsor: Centre Oscar Lambret · Feasibility of Pet-scan at Day 1 of Brachytherapy for Patients With Cervical Cancer
ClinicalTrials.gov · NCT03315351 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the trial record at 0.73name similarity 100% · shared principal investigator / founder · same therapeutic area
new_entity links the trial record at 0.53name similarity 100% · same therapeutic area

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Phase II trial registered: Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall
3w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall
3w agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Feasibility of Pet-scan at Day 1 of Brachytherapy for Patients With Cervical Cancer
4mo agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: Feasibility of Pet-scan at Day 1 of Brachytherapy for Patients With Cervical Cancer
4mo agoTrial completedSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Grant to raise

PHASE2 registered

NA registered